Fingerprint
Dive into the research topics of 'Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin Lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin Lymphoma
Heather Jacene, John Crandall, Yvette L. Kasamon, Richard F. Ambinder, Steven Piantadosi, Donna Serena, Wayne Kasecamp, Richard L. Wahl
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations